A study did the rounds recently with a striking message: summer sunshine isn’t enough to fix low vitamin D in people most at risk.
I read the press release, then the paper underneath it. The gap between the two is a useful lesson in reading health news—and in how easily a finding can become something stronger in translation than it was in the original research.
What was announced
The press release said vitamin D levels “didn’t improve, even in the summer months,” suggesting that people at higher risk shouldn’t assume time outdoors will solve the problem and may need to consider supplementation year-round.
It sounds plausible.
But what did the study actually measure?
What the study actually was
This was the screening stage of a supplement trial. People were recruited because of their age or skin type, both known risk factors for low vitamin D.
Each person gave a single finger-prick blood sample on the day they joined the study.
That’s important.
There was one measurement per person, with different people being measured in different months.
A snapshot like this can tell us how common low vitamin D was among these participants. It cannot tell us whether an individual’s vitamin D level rose or fell over the course of the summer, because no one was measured twice.
In other words, the study could describe a problem. It wasn’t designed to show change over time.
The study wasn’t the problem
This distinction matters.
The paper itself was careful. It reported the prevalence of vitamin D insufficiency, compared relevant subgroups, and concluded that low vitamin D was widespread among these at-risk participants.
Those conclusions are reasonable and supported by the design.
The leap happened in the translation.
The seasonal and causal framing—sunshine isn’t enough; levels don’t recover over summer—appeared in the public announcement, rather than being something the study itself could establish.
The study was funded by a company that sells vitamin D supplements, although the company had no role in the study’s design or interpretation. That’s worth knowing, but it’s not the main issue here. The more fundamental question is whether the evidence supports the claim being made.
Three things I check before I trust a finding
This is something I do regularly in my own work. Before a finding earns a place in a scientific narrative, I tend to run it through a few checks.
1. The methods: what was the study designed to do?
Start with the design.
Is the finding being used to answer the question the study was actually designed to address? And do the people studied resemble the population to whom the finding is now being applied?
In the vitamin D example, the answer matters because a cross-sectional snapshot cannot establish seasonal change within individuals.
The gap only becomes obvious when you look beyond the headline and read the methods.
2. The results: do they reflect the methods?
Next, I check whether the results actually match what the study set out to measure.
Is there enough information to understand what was measured and how the results were produced?
When results are reported without enough detail to follow the underlying analysis, that doesn’t necessarily mean they’re wrong. But something is missing—and that absence is worth noticing before leaning too heavily on the numbers.
3. The language: does the conclusion match the evidence?
Finally, I look at the words.
“May be associated with” is not “causes.”
A single study may suggest something; it rarely proves it.
A modest effect can quietly become “a major improvement,” and a result in one group can become a claim about everyone.
Good scientific communication keeps the confidence of the language in step with the confidence of the evidence.
What would actually answer the question?
Whether summer sun lifts vitamin D is a perfectly reasonable question.
But to answer whether people’s levels change across the seasons, you’d need a different study design—one that follows the same people and measures them at different points in time.
That’s the difference between describing a problem and explaining what changes it.
And it’s a distinction that matters far beyond vitamin D.
Whether I’m reading a study for a client, developing a scientific narrative, or trying to make sense of a health claim in the news, I come back to the same principle:
A finding is only as strong as the design behind it.
Before a headline changes what you think—or what you do—it’s worth asking not just what was found, but what the study could actually show.

Leave a comment